Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890785 · ClinicalTrials.gov registry record · Phase 1
Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01890785 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 30 participants.
The verdict
NCT01890785, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Compare the pharmacokinetic profiles when the contents are emptied into a soft food and orange juice compared to the SPD489 when swallowed as an intact capsule.
Interventions
- DRUG Lisdexamfetamine Dimesylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-07-15 |
| Est. Completion | 2013-08-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01890785
The ClinicalTrials.gov registry entry for NCT01890785 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lisdexamfetamine Dimesylate is the first listed.
NCT01890785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01890785 about?
NCT01890785 is a clinical study titled "Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers". Compare the pharmacokinetic profiles when the contents are emptied into a soft food and orange juice compared to the SPD489 when swallowed as an intact capsule.
What is the current status of trial NCT01890785?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2013-07-15. Estimated completion is 2013-08-22.
What interventions are being tested in trial NCT01890785?
The interventions under investigation include: Lisdexamfetamine Dimesylate (DRUG).
Who is sponsoring clinical trial NCT01890785?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.